|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Energeties of coal substitution by briquettes of agricultural residues显示文摘 | PALLAV PUROHIT ARUN KUMAR THIPATHI TARA CHANDRA KANDPA | 2006 | Energy2006，31，： | 1 |
| 2 | An approach to the estimation of thevalue of agricultural residues used as bio-fuels显示文摘 | ATUL KUMAR PALLAV PUROHIT | 2002 | Biomass&Bioenergy2002，22，3： | 1 |
| 3 | Advances in treatment and prevention of hepatitis B显示文摘Chronic hepatitis B(CHB)continues to contribute to worldwide morbidity and mortality significantly.Scientists,clinicians,pharmaceutical companies,and health organizations have dedicated substantial Intellectual and monetary resources to finding a cure,increasing immunization rates,and reducing the global burden of CHB.National and international health-related organizations including the center for disease control,the national institute of health,the American Association for the study of liver disease(AASLD),The European association for the study of the Liver(EASL),The Asia Pacific association for the study of the Liver(APASL)and the world health organization release periodic recommendations for disease prevention and treatment.Our review of the most recent guidelines by EASL,AASLD,APASL,and Taiwan Association for the Study of the Liver revealed that an overwhelming majority of cited studies were published before 2018.We reviewed Hepatitis B-related literature published 2018 onwards to identify recent developments and current barriers that will likely direct future efforts towards eradicating hepatitis B.The breakthrough in our understanding of the hepatitis B virus life cycle and resulting drug development is encouraging with significant room for further progress.Data from high-risk populations,most vulnerable to the devastating effects of hepatitis B infection and reactivation remain sparse.Utilization of systems approach,optimization of experimental models,identification and validation of next-generation biomarkers,and precise modulation of the human immune response will be critical for future innovation.Within the foreseeable future,new treatments will likely complement conventional therapies rather than replace them.Most Importantly,pragmatic management of CHB related population health challenges must be prioritized to produce real-world results. | Niraj James Shah Mark M Aloysius Neil Rohit Sharma Kumar Pallav | 2021 | World Journal of Gastrointestinal Pharmacology and Therapeutics2021，12，4： | 1 |
| 4 | Energelies of coal substitution by briquettes of agricuhural residues显示文摘 | PALLAV PLROHIT ARUN KUMAR TRIPATHI TARA CHANDRA KANDPA | 2006 | Energy2006，31，： | 1 |
| 5 | Energetics of coal substitution by briquettes of agricultural residues显示文摘 | Pallav Purohit Arun Kumar Tripathi Tara Chandra Kandpa | 2006 | Energy2006，31，89： | 1 |
| 6 | Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective显示文摘AIM To identify the predictors of vitamin D deficiency in patients with and without inflammatory bowel disease(IBD).METHODS Patients with ulcerative colitis(UC) or Crohn's disease(CD) related diagnostic codes who received medical care at University of Mississippi Medical Center between July 2012 and 2015 were identified. After thorough chart review, we identified patients with biopsy proven IBD who had also been tested for serum 25-hydroxyvitamin D [25(OH)D] concentration. We compared these patients to a previously studied cohort of healthy controls who also had vitamin D concentration checked. Logistic regression analysis was performed to determine the association between vitamin d deficiency and UC, CD, race, age, gender and body mass index(BMI).RESULTS We identified 237 patients with confirmed IBD. Of these, only 211 had a serum 25(OH)D concentrations available in the medical record. The group of healthy controls consisted of 98 individuals with available serum 25(OH)D concentration. 43% of IBD patients were African American(AA). Patients with CD were more likely to have vitamin D concentration checked. Bivariate analysis showed that AA(51% vs 21%, P= 0.00001), subjects with BMI > 30 kg/m^2(39% vs 23% P = 0.01) and CD(40% vs 26%, P = 0.04) were more likely to be vitamin D deficient than vitamin D sufficient. Those with Age > 65 were more likely to be vitamin D sufficient(46% vs 15%, P = 0.04). Multiple regression showed that only BMI > 30 kg/m^2 and AA race are associated with vitamin D deficiency. CONCLUSION BMI > 30 kg/m^2 and AA race are predictive of vitamin D deficiency. Gender, age and diagnosis of IBD are not predictive of vitamin D deficiency. | Kumar Pallav Daniel Riche Warren L May Patrick Sanchez Nitin K Gupta | 2017 | World Journal of Gastroenterology2017，23，4： | 1 |
| 7 | Energetics of coal substi- tution by briquettes of agricultural residues显示文摘 | PALLAV PUROH1T ARUN KUMAR TRIPATHI TARA CHANDRA KANDPA | 2006 | Energy2006，31，： | 1 |
| 8 | Energetics of coal substitution by briquettes of agricultural residues显示文摘 | PALLAV PUROHIT ARUN KUMAR TRIPATHI TARA CHANDRA KANDPA | 2006 | Energy2006，，31： | 1 |
| 9 | An approach to the estimation of the value of agricultural residues used as bio-fuels 显示文摘 | Atul Kumar Pallav Purohit | 2002 | Biomass & Bioenergy2002，22，3： | 1 |
| 10 | Escherichia coli O157:H7 sepsis following fecal microbiota transplant in an IgA-deficient inflammatory bowel disease patient显示文摘Introduction Clostridioides difficile infection(CDI)is a common gastrointestinal illness worldwide,with increased prevalence and worse outcomes in patients with inflammatory bowel disease(IBD)[1].Fecal microbiota transplant(FMT)is an effective treatment for recurrent CDIs(RCDIs)with minimal serious adverse events(SAEs)reported[2].While immunosuppressive medications increase susceptibility to infections,studies have shown that FMT does not increase SAE risk in immunocompromised patients(including IBD patients on immunosuppressive therapy)[3]. | Landen S.Burstiner Jared Silver Logan J.Burstiner Arian Teymoorian Kumar Pallav Demarre Jones Anna Owings Sarah Glover | 2022 | Gastroenterology Report2022，10，1： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员